Azafaros B.V.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-34
RECRUITING2
READOUTS ≤12 MONTHS1
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| PRISMA NCT07399704 |
P2 | Active, not recruiting | GM2 Gangliosidosis; Niemann-Pick Type C Disease | 21 | 2027-06-30 |
| AZ-3102 NCT07715084 |
P2 | Not yet recruiting | Gaucher Disease Type 3 | 20 | 2028-01 |
| AZ-3102 NCT07082543 |
P3 | Active, not recruiting | Gangliosidoses, GM2; Gangliosidosis, GM1 | 75 | 2028-02-06 (+3 mo) |
| AZ-3102 NCT07054515 |
P3 | Recruiting | Niemann-Pick Type C Disease; GM1 Gangliosidosis | 147 | 2028-05-14 (+6 mo) |
| Nizubaglustat NCT07082725 |
P3 | Recruiting | Niemann-Pick Type C Disease | 72 | 2028-05-14 (+6 mo) |
| HARBOR NCT07885917 |
P2/3 | Not yet recruiting | Niemann-Pick Disease Type C; GM2 Gangliosidosis | 218 | 2030-04-01 |